Swiss Medical Regulatory

International Coalition of Medicines Regulatory Authorities (ICMRA)

The International Coalition of Medicines Regulatory Authorities (ICMRA) is a strategic coordinating entity for regulatory authorities, enhancing global communication, information sharing, and crisis response for medicines.

The International Coalition of Medicines Regulatory Authorities (ICMRA) is a voluntary, executive-level entity focused on strategic coordination, advocacy, and leadership among regulatory authorities. Its mission is to provide a global architecture that supports enhanced communication, information sharing, and crisis response, while also addressing regulatory science issues. ICMRA aims to tackle current and emerging human medicine regulatory and safety challenges on a global scale. The organization is designed to facilitate collaboration and streamline responses to critical issues within the field of medicine regulation. The website itself was designed by Swissmedic and is maintained by the Pharmaceuticals and Medical Devices Agency, indicating a collaborative effort in its operational infrastructure.

About

**Who they are**
Swiss Medical Regulatory is an entity associated with the International Coalition of Medicines Regulatory Authorities (ICMRA), which serves as a strategic coordinating body for regulatory authorities globally. The website content indicates that the ICMRA Secretariat can be contacted via email, and the website itself was designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency.

**Expertise & scope**
* Facilitates global communication and information sharing among medicines regulatory authorities.
* Enhances crisis response capabilities for medicines.
* Addresses current and emerging human medicine regulatory and safety challenges globally and strategically.
* Supports the addressing of regulatory science issues.

**Reputation / proof points**
* The ICMRA website is designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency.

Additional information

The International Coalition of Medicines Regulatory Authorities (ICMRA) operates as a collaborative platform for regulatory bodies. Its activities focus on enhancing international cooperation, sharing critical information, and coordinating responses to global health crises related to medicines. The organization's structure and initiatives are guided by its participating regulatory authorities, with a focus on addressing both current and emerging challenges in medicine regulation and safety.

Key Highlights

  • The ICMRA Secretariat can be contacted at ICMRASecretariat@health.gov.au. Source
    “ICMRA Secretariat can be contacted at ICMRASecretariat@health.gov.au.”
  • The website was designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency. Source
    “Website designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency”
  • Professor Anthony (Tony) Lawler began his mandate as ICMRA Chair on 23 October 2025. Source
    “The Chair of the International Coalition of Medicines Regulatory Authorities (ICMRA) is Professor Anthony (Tony) Lawler. He began his mandate as ICMRA Chair on 23 October 2025.”

Certifications & Trust Signals

  • The International Coalition of Medicines Regulatory Authorities (ICMRA) is a strategic coordinating entity for regulatory authorities. Source
    “The International Coalition of Medicines Regulatory Authorities (ICMRA) is a strategic coordinating entity for regulatory authorities, enhancing global communication, information sharing, and crisis response for medicines.”

Buyer Snapshot

Best for
  • Entities seeking international regulatory coordination insights
  • Organizations interested in global medicines regulation
How engagement typically works
  • Information-based engagement through website content
  • Collaboration with international regulatory authorities
Typical deliverables
  • Insights into global regulatory strategies
  • Information on international crisis response for medicines
Good to know
  • Best when buyer is seeking information on international regulatory bodies rather than direct Swiss representation services.
HQ: Geneva, Switzerland
Languages: English, German, French
Timezones: Europe/Zurich
Claim status: Listed

Services & Capabilities

Find CH-REP (Swiss Authorized Rep) | Compare & Get Quotes

Jurisdictions: CH
Countries: CH
Industries: Medical devices, IVD
Portfolio: 6-25
Onboarding time: 3–10 days
Pricing model: Custom pricing
Starting from: CHF 2,100
Included services: Swissmedic contact point handling, Vigilance and incident reporting coordination, Labeling/packaging CH-REP information alignment, Mandate administration and documentation availability
Swiss Local Contact: No
Labeling Support: No
Can Be Named On Label: No
Vigilance Contact Support: No
Swiss Entity Canton Or Region: CH

Additional ch_rep Details

Supports MDR
true
Supports IVDR
true
Swiss Entity Canton Or Region
CH
Labeling Support
true
Swiss Local Contact
true
Vigilance Contact Support
true
Can Be Named On Label
true
Request quotes
⚡ Instant booking available
Appoint a Swiss Authorized Representative (CH-REP) for Medical Devices
Compare Swiss Medical Regulatory and other vetted providers — instant pricing, no RFQ needed.
Book now — instant pricing →
Cruxi - Regulatory Compliance Services